Global Implantable Drug-Eluting Devices Market Insights, Forecast to 2025

Published: December 2019

No. of Pages: 119

Price:

Single User License: US $ 4900 US $ 3675
Corporate User License: US $ 9800 US $ 7350

Report Description
Table of Contents

Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
The global Implantable Drug-Eluting Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Implantable Drug-Eluting Devices market based on company, product type, end user and key regions.

This report studies the global market size of Implantable Drug-Eluting Devices in key regions like North America, Europe and China, focuses on the consumption of Implantable Drug-Eluting Devices in these regions.
This research report categorizes the global Implantable Drug-Eluting Devices market by top players/brands, region, type and end user. This report also studies the global Implantable Drug-Eluting Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
- Pfizer
- Medtronic
- Merck
- Bayer AG
- Johnson & Johnson
- Abbott
- Surmodics
- Boston Scientific Corporation
- Titan Pharmaceuticals, Inc.
- BIOTRONIK
- Allergan
- Bausch & Lomb
- REVA Medical
- MicroPort Medical

Implantable Drug-Eluting Devices market size by Type
- Implantable Drug Infusion Pumps
- Intraocular Drug-Eluting Devices
- Contraceptive Drug-Eluting Devices
- Drug-Eluting Stents
- Others

Implantable Drug-Eluting Devices market size by Applications
- Diabetes
- Contraception
- HIV/AIDS Prevention
- Chronic Pain Management
- Cardiovascular
- Ophthalmology
- Oncology
- Others

Market size by Region
- North America
- - United States
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Central & South America
- - Brazil
- Middle East & Africa
- - Turkey
- - GCC Countries
- - Egypt
- - South Africa

The study objectives of this report are:
- To study and analyze the global Implantable Drug-Eluting Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
- To understand the structure of Implantable Drug-Eluting Devices market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Implantable Drug-Eluting Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
- To project the value and sales volume of Implantable Drug-Eluting Devices submarkets, with respect to key regions.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Implantable Drug-Eluting Devices are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Implantable Drug-Eluting Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Implantable Drug-Eluting Devices Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type
1.4.2 Implantable Drug Infusion Pumps
1.4.3 Intraocular Drug-Eluting Devices
1.4.4 Contraceptive Drug-Eluting Devices
1.4.5 Drug-Eluting Stents
1.4.6 Others
1.5 Market by Application
1.5.1 Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application
1.5.2 Diabetes
1.5.3 Contraception
1.5.4 HIV/AIDS Prevention
1.5.5 Chronic Pain Management
1.5.6 Cardiovascular
1.5.7 Ophthalmology
1.5.8 Oncology
1.5.9 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Implantable Drug-Eluting Devices Market Size
2.1.1 Global Implantable Drug-Eluting Devices Revenue 2014-2025
2.1.2 Global Implantable Drug-Eluting Devices Sales 2014-2025
2.2 Implantable Drug-Eluting Devices Growth Rate by Regions
2.2.1 Global Implantable Drug-Eluting Devices Sales by Regions
2.2.2 Global Implantable Drug-Eluting Devices Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Implantable Drug-Eluting Devices Sales by Manufacturers
3.1.1 Implantable Drug-Eluting Devices Sales by Manufacturers
3.1.2 Implantable Drug-Eluting Devices Sales Market Share by Manufacturers
3.2 Implantable Drug-Eluting Devices Revenue by Manufacturers
3.2.1 Implantable Drug-Eluting Devices Revenue by Manufacturers (2014-2019)
3.2.2 Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2014-2019)
3.3 Implantable Drug-Eluting Devices Price by Manufacturers
3.4 Implantable Drug-Eluting Devices Manufacturing Base Distribution, Product Types
3.4.1 Implantable Drug-Eluting Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Implantable Drug-Eluting Devices Product Type
3.4.3 Date of International Manufacturers Enter into Implantable Drug-Eluting Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Implantable Drug-Eluting Devices Sales by Type
4.2 Global Implantable Drug-Eluting Devices Revenue by Type
4.3 Implantable Drug-Eluting Devices Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Implantable Drug-Eluting Devices Breakdown Data by Application

6 North America
6.1 North America Implantable Drug-Eluting Devices by Country
6.1.1 North America Implantable Drug-Eluting Devices Sales by Country
6.1.2 North America Implantable Drug-Eluting Devices Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Implantable Drug-Eluting Devices by Type
6.3 North America Implantable Drug-Eluting Devices by Application

7 Europe
7.1 Europe Implantable Drug-Eluting Devices by Country
7.1.1 Europe Implantable Drug-Eluting Devices Sales by Country
7.1.2 Europe Implantable Drug-Eluting Devices Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Implantable Drug-Eluting Devices by Type
7.3 Europe Implantable Drug-Eluting Devices by Application

8 Asia Pacific
8.1 Asia Pacific Implantable Drug-Eluting Devices by Region
8.1.1 Asia Pacific Implantable Drug-Eluting Devices Sales by Region
8.1.2 Asia Pacific Implantable Drug-Eluting Devices Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Implantable Drug-Eluting Devices by Type
8.3 Asia Pacific Implantable Drug-Eluting Devices by Application

9 Central & South America
9.1 Central & South America Implantable Drug-Eluting Devices by Country
9.1.1 Central & South America Implantable Drug-Eluting Devices Sales by Country
9.1.2 Central & South America Implantable Drug-Eluting Devices Revenue by Country
9.1.3 Brazil
9.2 Central & South America Implantable Drug-Eluting Devices by Type
9.3 Central & South America Implantable Drug-Eluting Devices by Application

10 Middle East and Africa
10.1 Middle East and Africa Implantable Drug-Eluting Devices by Country
10.1.1 Middle East and Africa Implantable Drug-Eluting Devices Sales by Country
10.1.2 Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Implantable Drug-Eluting Devices by Type
10.3 Middle East and Africa Implantable Drug-Eluting Devices by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Implantable Drug-Eluting Devices Products Offered
11.1.5 Pfizer Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Medtronic Implantable Drug-Eluting Devices Products Offered
11.2.5 Medtronic Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Implantable Drug-Eluting Devices Products Offered
11.3.5 Merck Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Company Business Overview
11.4.3 Bayer AG Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Bayer AG Implantable Drug-Eluting Devices Products Offered
11.4.5 Bayer AG Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Company Business Overview
11.6.3 Abbott Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Abbott Implantable Drug-Eluting Devices Products Offered
11.6.5 Abbott Recent Development
11.7 Surmodics
11.7.1 Surmodics Company Details
11.7.2 Company Business Overview
11.7.3 Surmodics Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Surmodics Implantable Drug-Eluting Devices Products Offered
11.7.5 Surmodics Recent Development
11.8 Boston Scientific Corporation
11.8.1 Boston Scientific Corporation Company Details
11.8.2 Company Business Overview
11.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Products Offered
11.8.5 Boston Scientific Corporation Recent Development
11.9 Titan Pharmaceuticals, Inc.
11.9.1 Titan Pharmaceuticals, Inc. Company Details
11.9.2 Company Business Overview
11.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Products Offered
11.9.5 Titan Pharmaceuticals, Inc. Recent Development
11.10 BIOTRONIK
11.10.1 BIOTRONIK Company Details
11.10.2 Company Business Overview
11.10.3 BIOTRONIK Implantable Drug-Eluting Devices Sales, Revenue and Gross Margin (2014-2019)
11.10.4 BIOTRONIK Implantable Drug-Eluting Devices Products Offered
11.10.5 BIOTRONIK Recent Development
11.11 Allergan
11.12 Bausch & Lomb
11.13 REVA Medical
11.14 MicroPort Medical

12 Future Forecast
12.1 Implantable Drug-Eluting Devices Market Forecast by Regions
12.1.1 Global Implantable Drug-Eluting Devices Sales Forecast by Regions 2019-2025
12.1.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Regions 2019-2025
12.2 Implantable Drug-Eluting Devices Market Forecast by Type
12.2.1 Global Implantable Drug-Eluting Devices Sales Forecast by Type 2019-2025
12.2.2 Global Implantable Drug-Eluting Devices Revenue Forecast by Type 2019-2025
12.3 Implantable Drug-Eluting Devices Market Forecast by Application
12.4 North America Implantable Drug-Eluting Devices Forecast
12.5 Europe Implantable Drug-Eluting Devices Forecast
12.6 Asia Pacific Implantable Drug-Eluting Devices Forecast
12.7 Central & South America Implantable Drug-Eluting Devices Forecast
12.8 Middle East and Africa Implantable Drug-Eluting Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Implantable Drug-Eluting Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures

Figure Implantable Drug-Eluting Devices Product Picture
Table Implantable Drug-Eluting Devices Market Segments
Table Key Manufacturers Implantable Drug-Eluting Devices Covered
Table Global Implantable Drug-Eluting Devices Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2018 & 2025
Figure Implantable Drug Infusion Pumps Product Picture
Table Major Manufacturers of Implantable Drug Infusion Pumps
Figure Intraocular Drug-Eluting Devices Product Picture
Table Major Manufacturers of Intraocular Drug-Eluting Devices
Figure Contraceptive Drug-Eluting Devices Product Picture
Table Major Manufacturers of Contraceptive Drug-Eluting Devices
Figure Drug-Eluting Stents Product Picture
Table Major Manufacturers of Drug-Eluting Stents
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Implantable Drug-Eluting Devices Market Size Growth Rate by Application 2019-2025 (K Units)
Figure Global Implantable Drug-Eluting Devices 4900 Sales Market Share by Application in 2018
Figure Diabetes
Figure Contraception
Figure HIV/AIDS Prevention
Figure Chronic Pain Management
Figure Cardiovascular
Figure Ophthalmology
Figure Oncology
Figure Others
Figure Implantable Drug-Eluting Devices Report Years Considered
Figure Global Implantable Drug-Eluting Devices Market Size 2014-2025 (Million US$)
Figure Global Implantable Drug-Eluting Devices Sales 2014-2025 (K Units)
Table Global Implantable Drug-Eluting Devices Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Implantable Drug-Eluting Devices Sales by Regions 2014-2019 (K Units)
Table Global Implantable Drug-Eluting Devices Sales Market Share by Regions 2014-2019
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Regions 2014-2019
Figure 2018 Global Implantable Drug-Eluting Devices Sales Market Share by Regions
Table Global Implantable Drug-Eluting Devices Revenue by Regions 2014-2019 (Million US$)
Table Global Implantable Drug-Eluting Devices Revenue Market Share by Regions 2014-2019
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Regions 2014-2019
Figure 2018 Global Implantable Drug-Eluting Devices Revenue Market Share by Regions
Table Global Implantable Drug-Eluting Devices Sales by Manufacturers (2014-2019) (K Units)
Table Global Implantable Drug-Eluting Devices Sales Share by Manufacturers (2014-2019)
Figure Global Implantable Drug-Eluting Devices Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Implantable Drug-Eluting Devices Revenue by Manufacturers (2014-2019) (Million USD)
Table Implantable Drug-Eluting Devices Revenue Share by Manufacturers (2014-2019)
Figure Implantable Drug-Eluting Devices Value Share by Manufacturers in 2018
Table Key Manufacturers Implantable Drug-Eluting Devices Price (2014-2019) (USD/Unit)
Table Implantable Drug-Eluting Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Implantable Drug-Eluting Devices Product Type
Table Date of International Manufacturers Enter into Implantable Drug-Eluting Devices Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table Global Implantable Drug-Eluting Devices Sales Share by Type (2014-2019)
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2018
Table Global Implantable Drug-Eluting Devices Revenue by Type (2014-2019) (Million US$)
Table Global Implantable Drug-Eluting Devices Revenue Share by Type (2014-2019)
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2014-2019)
Figure Global Implantable Drug-Eluting Devices Revenue Market Share by Type in 2018
Table Implantable Drug-Eluting Devices Price by Type 2014-2019 (USD/Unit)
Table Global Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table Global Implantable Drug-Eluting Devices Sales Share by Application (2014-2019)
Figure Global Sales Implantable Drug-Eluting Devices Market Share by Application (2014-2019)
Figure Global Sales Implantable Drug-Eluting Devices Market Share by Application in 2018
Figure North America Implantable Drug-Eluting Devices Sales Growth Rate 2014-2019 (K Units)
Figure North America Implantable Drug-Eluting Devices Revenue Growth Rate 2014-2019 (Million US$)
Table North America Implantable Drug-Eluting Devices Sales by Country (2014-2019) (K Units)
Table North America Implantable Drug-Eluting Devices Sales Market Share by Country (2014-2019)
Figure 2018 North America Implantable Drug-Eluting Devices Sales Market Share by Country
Table North America Implantable Drug-Eluting Devices Revenue by Country (2014-2019) (Million US$)
Table North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2014-2019)
Figure 2018 North America Implantable Drug-Eluting Devices Revenue Market Share by Country
Figure United States Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure United States Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Canada Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Table North America Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table North America Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure 2018 North America Implantable Drug-Eluting Devices Market Share by Type
Table North America Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table North America Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
Figure 2018 North America Implantable Drug-Eluting Devices Market Share by Application
Figure Europe Implantable Drug-Eluting Devices Sales Growth Rate 2014-2019 (K Units)
Figure Europe Implantable Drug-Eluting Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Implantable Drug-Eluting Devices Sales by Country (2014-2019) (K Units)
Table Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2014-2019)
Figure 2018 Europe Implantable Drug-Eluting Devices Sales Market Share by Country
Table Europe Implantable Drug-Eluting Devices Revenue by Country (2014-2019) (Million US$)
Table Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2014-2019)
Figure 2018 Europe Implantable Drug-Eluting Devices Revenue Market Share by Country
Figure Germany Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Germany Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure France Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure France Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure UK Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Italy Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Russia Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure 2018 Europe Implantable Drug-Eluting Devices Market Share by Type
Table Europe Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
Figure 2018 Europe Implantable Drug-Eluting Devices Market Share by Application
Figure Asia Pacific Implantable Drug-Eluting Devices Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Implantable Drug-Eluting Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Implantable Drug-Eluting Devices Sales by Region (2014-2019) (K Units)
Table Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Region
Table Asia Pacific Implantable Drug-Eluting Devices Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific Implantable Drug-Eluting Devices Revenue Market Share by Country
Figure China Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure China Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Japan Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure South Korea Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure India Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure India Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Australia Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific Implantable Drug-Eluting Devices Market Share by Type
Table Asia Pacific Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table Asia Pacific Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific Implantable Drug-Eluting Devices Market Share by Application
Figure Central & South America Implantable Drug-Eluting Devices Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Implantable Drug-Eluting Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Implantable Drug-Eluting Devices Sales by Country (2014-2019) (K Units)
Table Central & South America Implantable Drug-Eluting Devices Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America Implantable Drug-Eluting Devices Sales Market Share by Country
Table Central & South America Implantable Drug-Eluting Devices Revenue by Country (2014-2019) (Million US$)
Table Central & South America Implantable Drug-Eluting Devices Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America Implantable Drug-Eluting Devices Revenue Market Share by Country
Figure Brazil Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table Central & South America Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America Implantable Drug-Eluting Devices Market Share by Type
Table Central & South America Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table Central & South America Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America Implantable Drug-Eluting Devices Market Share by Application
Figure Middle East and Africa Implantable Drug-Eluting Devices Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Implantable Drug-Eluting Devices Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales by Country (2014-2019) (K Units)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Country
Table Middle East and Africa Implantable Drug-Eluting Devices Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa Implantable Drug-Eluting Devices Revenue Market Share by Country
Figure Turkey Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Implantable Drug-Eluting Devices Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Implantable Drug-Eluting Devices Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales by Type (2014-2019) (K Units)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa Implantable Drug-Eluting Devices Market Share by Type
Table Middle East and Africa Implantable Drug-Eluting Devices Sales by Application (2014-2019) (K Units)
Table Middle East and Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa Implantable Drug-Eluting Devices Market Share by Application
Table Pfizer Company Details
Table Pfizer Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Medtronic Company Details
Table Medtronic Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medtronic Recent Development

Table Merck Company Details
Table Merck Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Bayer AG Company Details
Table Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Recent Development

Table Johnson & Johnson Company Details
Table Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development

Table Abbott Company Details
Table Abbott Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development

Table Surmodics Company Details
Table Surmodics Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Surmodics Recent Development

Table Boston Scientific Corporation Company Details
Table Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boston Scientific Corporation Recent Development

Table Titan Pharmaceuticals, Inc. Company Details
Table Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Titan Pharmaceuticals, Inc. Recent Development

Table BIOTRONIK Company Details
Table BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOTRONIK Recent Development

Table Allergan Company Details
Table Bausch & Lomb Company Details
Table REVA Medical Company Details
Table MicroPort Medical Company Details
Table Global Implantable Drug-Eluting Devices Sales Forecast by Regions 2019-2025 (K Units)
Table Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Regions 2019-2025
Table Global Implantable Drug-Eluting Devices Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Regions 2019-2025
Table Global Implantable Drug-Eluting Devices Sales Forecast by Type 2019-2025 (K Units)
Table Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Type 2019-2025
Table Global Implantable Drug-Eluting Devices Revenue Forecast by Type 2019-2025 (Million US$)
Table Global Implantable Drug-Eluting Devices Revenue Market Share Forecast by Type 2019-2025
Table Global Implantable Drug-Eluting Devices Sales Forecast by Application 2019-2025 (K Units)
Table Global Implantable Drug-Eluting Devices Sales Market Share Forecast by Application 2019-2025
Figure North America Implantable Drug-Eluting Devices Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Implantable Drug-Eluting Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Implantable Drug-Eluting Devices Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Implantable Drug-Eluting Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Implantable Drug-Eluting Devices Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Implantable Drug-Eluting Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Implantable Drug-Eluting Devices Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Implantable Drug-Eluting Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Implantable Drug-Eluting Devices Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Implantable Drug-Eluting Devices Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table Implantable Drug-Eluting Devices Value Chain
Table Implantable Drug-Eluting Devices Customers List
Figure Channels of Distribution
Table Implantable Drug-Eluting Devices Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group625881

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

2020-2025 Global and Regional Implantable Drug-Eluting Devices Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report HNY Research projects that the Implantable Drug-Eluting Devices market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025....
COVID-19 Impact on Global Implantable Drug-Eluting Devices Market Insights, Forecast to 2026 Implantable Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Implantable Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powe...
Global Implantable Drug-Eluting Devices Market Research Report 2020 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segme...
Global Implantable Drug-Eluting Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 Description Scope of the Report: The worldwide market for Implantable Drug-Eluting Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, ac...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *